EVIDENCE BASED DATA
The strongest team of multidisciplinary pharmacogenetics, who are the most cited and productive researchers in various areas of pharmacotherapy (narcology, psychiatry, cardiology, neurology, gynecology, etc) in the Russian Federation and the CIS countries, contributes to the creation of a daily updated scientific basis of PGX2.
The PGX2 team has over 100 scientific publications in just 2 years of collaboration. The technology allows to integrate machine deep learning with advanced knowledge of the world pharmacogenetics of Level of evidence 1 to the daily practice of physicians.
NEWS
11.02.2021
The PGX2 team took part in the Investor Day at the Skolkovo School of Management.
08.02.2021
PGX2 CEO – winner of the International Medical Forum "Science. Innovations».
01.02.2021
PGX2 Science Director accepted into the Royal College of Psychiatrists.
31.12.2020
PGX2 summed up 2020 results.
10.12.2020
PGX2 Development Director became the winner of the GSEA MedTech Ru 20-21.